Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel

Introduction: Praziquantel (PZQ) is the only commercially available drug for schistosomiasis. The current shortage of alternative effective drugs and the lack of successful preventive measures enhance its value. The increase in the prevalence of PZQ resistance under sustained drug pressure is, ther...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomédica
Main Authors: Eglal I. Amer, Iman F. Abou-El-Naga, Laila M. Boulos, Heba S. Ramadan, Salwa S. Younis
Formato: Artigo
Idioma:Inglês
Publicado: Instituto Nacional de Salud 2022
Assuntos:
Medicina
liposomes
praziquantel
drug resistance
Schistosoma mansoni
Acceso en liña:https://www.redalyc.org/articulo.oa?id=84371265007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares